Eliem Therapeutics
Stock Forecast, Prediction & Price Target

Eliem Therapeutics Financial Estimates

Eliem Therapeutics Revenue Estimates

Eliem Therapeutics EBITDA Estimates

Eliem Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Net Income
 
% change YoY
$-47.48M
 
N/A
$-45.35M
 
4.47%
$-35.11M
 
22.56%
Avg: $-16.73M
Low: $-16.73M
High: $-16.73M
avg. 52.35%
Avg: $-18.62M
Low: $-18.62M
High: $-18.62M
avg. -11.29%
Avg: $-26.17M
Low: $-26.17M
High: $-26.17M
avg. -40.57%
EBITDA
 
% change YoY
$-35.50M
 
N/A
$-43.65M
 
-22.95%
$-13.65M
 
68.72%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$1.81
 
N/A
-$1.72
 
4.97%
-$1.3
 
24.41%
Avg: -$0.62
Low: -$0.62
High: -$0.62
avg. 52.30%
Avg: -$0.69
Low: -$0.69
High: -$0.69
avg. -11.29%
Avg: -$0.97
Low: -$0.97
High: -$0.97
avg. -40.57%
Operating Expenses
 
% change YoY
$35.67M
 
N/A
$45.13M
 
26.52%
$37.40M
 
-17.11%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Eliem Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 0.16% in 2025-2027.

We have gathered data from N/A analysts. Their low estimate is -16.73M, average is -16.73M and high is -16.73M.

What is Eliem Therapeutics stock revenue growth forecast?

We have gathered data from N/A analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Eliem Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 0.14% in 2025-2027.

We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.62, average is -$0.62 and high is $-0.62.